AbbVie and AstraZeneca filed a pair of lawsuits to block Minnesota's law barring manufacturer 340B contract pharmacy restrictions.

BREAKING: Developments in AstraZeneca’s 340B Lawsuit

A federal district judge in Wilmington, Del., this morning gave the federal government until 11:00 a.m. Eastern tomorrow to respond to AstraZeneca’s emergency motion yesterday for a stay in its lawsuit over the government’s efforts to compel it to resume 340B pricing on drugs dispensed by contract pharmacies.

AstraZeneca will have until 6:00 p.m. tomorrow to respond to the government’s filing.

AstraZeneca yesterday asked U.S. District Judge Leonard Stark “for a short administrative stay to temporarily preserve the status quo” in its lawsuit against the government, in light of the U.S. Health Resources and Services Administration (HRSA)’s June 1 deadline for AstraZeneca and five other manufacturers to resume 340B pricing on drugs dispensed by contract pharmacies and to give covered entities credits or refunds for any related overcharges.

This is a developing story.